Clinical approach to the critically ill, morbidly obese patient.
暂无分享,去创建一个
[1] T. Bates,et al. The use of the Body Mass Index in studies of abdominal wound infection. , 1992, The Journal of hospital infection.
[2] S. Burns,et al. Effect of body position on spontaneous respiratory rate and tidal volume in patients with obesity, abdominal distension and ascites. , 1994, American journal of critical care : an official publication, American Association of Critical-Care Nurses.
[3] J. Brock‐Utne,et al. Morbid Obesity and Tracheal Intubation , 2002, Anesthesia and analgesia.
[4] J. Helterbrand,et al. Pharmacokinetic‐pharmacodynamic analysis of drotrecogin alfa (activated) in patients with severe sepsis , 2002, Clinical pharmacology and therapeutics.
[5] G. Bailie,et al. Pharmacokinetics of propofol during and after long-term continuous infusion for maintenance of sedation in ICU patients. , 1992, British journal of anaesthesia.
[6] P. Wade,et al. Sedation in the Intensive-care Unit , 1984, The Lancet.
[7] P. Dodek,et al. Intravenous insulin nomogram improves blood glucose control in the critically ill , 2001, Critical care medicine.
[8] A. El‐Solh,et al. Morbid obesity in the medical ICU. , 2001, Chest.
[9] H. Sugerman,et al. Risks and Benefits of Gastric Bypass in Morbidly Obese Patients With Severe Venous Stasis Disease , 2001, Annals of surgery.
[10] S. Nasraway,et al. Practice parameters for intravenous analgesia and sedation for adult patients in the intensive care unit: an executive summary. Society of Critical Care Medicine. , 1995, Critical care medicine.
[11] L. Hidalgo. Dermatological Complications of Obesity , 2002 .
[12] J. Kress,et al. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. , 2000, The New England journal of medicine.
[13] M. Laposata,et al. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: the clinical use and laboratory monitoring of low-molecular-weight heparin, danaparoid, hirudin and related compounds, and argatroban. , 1998, Archives of Pathology & Laboratory Medicine.
[14] T. Ishizaki,et al. Propofol decreases the clearance of midazolam by inhibiting CYP3A4: an in vivo and in vitro study , 1999, Clinical pharmacology and therapeutics.
[15] K. Rodvold,et al. Antimicrobial dosing in obese patients. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[16] J. Barrett,et al. Dosing in Heavy-weight/Obese Patients with the LMWH, Tinzaparin: A Pharmacodynamic Study , 2002, Thrombosis and Haemostasis.
[17] G. L. Bloomfield,et al. Abdominal compartment syndrome. , 1998, The Journal of trauma.
[18] H. Sugerman,et al. Intra‐abdominal pressure, sagittal abdominal diameter and obesity comorbidity , 1997, Journal of internal medicine.
[19] G. Angelini,et al. Use of propofol and other nonbenzodiazepine sedatives in the intensive care unit. , 2001, Critical care clinics.
[20] R. Dickerson,et al. Hypocaloric enteral tube feeding in critically ill obese patients. , 2002, Nutrition.
[21] G. Foster. Principles and practices in the management of obesity. , 2003, American journal of respiratory and critical care medicine.
[22] J G Reves,et al. Midazolam: Pharmacology and Uses , 1985, Anesthesiology.
[23] B A Carroll,et al. The diagnostic approach to acute venous thromboembolism. Clinical practice guideline. American Thoracic Society. , 1999, American journal of respiratory and critical care medicine.
[24] D. Arnaudov,et al. Validation Study of Two-microphone Acoustic Reflectometry for Determination of Breathing Tube Placement in 200 Adult Patients , 2002, Anesthesiology.
[25] R. B. Becker,et al. Facilitation of internal jugular venous cannulation using an audio-guided Doppler ultrasound vascular access device: results from a prospective, dual-center, randomized, crossover clinical study. , 1995, Critical care medicine.
[26] M. Ellersieck,et al. Predicting energy needs in ventilator-dependent critically ill patients: effect of adjusting weight for edema or adiposity. , 1997, The American journal of clinical nutrition.
[27] M. Naguib,et al. Predictive models for difficult laryngoscopy and intubation. A clinical, radiologic and three-dimensional computer imaging study , 1999, Canadian journal of anaesthesia = Journal canadien d'anesthesie.
[28] H. Brem,et al. Pressure ulcers in the chronically critically ill patient. , 2002, Critical care clinics.
[29] P. Choban,et al. The impact of obesity on surgical outcomes: a review. , 1997, Journal of the American College of Surgeons.
[30] I. Kehagias,et al. Prophylaxis of Venous Thromboembolism Using Two Different Doses of Low-Molecular-Weight Heparin (Nadroparin) in Bariatric Surgery: A Prospective Randomized Trial , 2001, Obesity surgery.
[31] G. Barat,et al. Positive end‐expiratory pressure , 1975, Anaesthesia.
[32] W. Pories,et al. Prophylactic cefazolin in gastric bypass surgery. , 1981, Surgery.
[33] C A Beam,et al. 1992 ARRS Executive Council Award. Detection of deep venous thrombosis: prospective comparison of MR imaging with contrast venography. , 1993, AJR. American journal of roentgenology.
[34] N. Rawal,et al. Comparison of Intramuscular and Epidural Morphine for Postoperative Analgesia in the Grossly Obese: Influence on Postoperative Ambulation and Pulmonary Function , 1984, Anesthesia and analgesia.
[35] P. Pelosi,et al. Total respiratory system, lung, and chest wall mechanics in sedated-paralyzed postoperative morbidly obese patients. , 1996, Chest.
[36] A. Ernst,et al. Safety of bedside percutaneous dilatational tracheostomy in obese patients in the ICU. , 2000, Chest.
[37] C. Ireton-Jones,et al. Obesity: nutrition support practice and application to critical care. , 1995, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.
[38] J. Canet,et al. Acid aspiration prophylaxis in morbidly obese patients: famotidine vs. ranitidine , 1991, Anaesthesia.
[39] G. Adams,et al. Permanent tracheostomy with cervical lipectomy , 1990, The Laryngoscope.
[40] R. K. Webb,et al. Difficult Intubation: An Analysis of 2000 Incident Reports , 1993 .
[41] M. Ramsay,et al. Controlled Sedation with Alphaxalone-Alphadolone , 1974, British medical journal.
[42] J. Cardella,et al. Interventional radiologic placement of peripherally inserted central catheters. , 1993, Journal of Vascular and Interventional Radiology.
[43] M. Jeevanandam,et al. Obesity and the metabolic response to severe multiple trauma in man. , 1991, The Journal of clinical investigation.
[44] M. Lamy,et al. Effect of bi-level positive airway pressure (BiPAP) nasal ventilation on the postoperative pulmonary restrictive syndrome in obese patients undergoing gastroplasty. , 1997, Chest.
[45] F. Donati,et al. Influence of extreme obesity on the body disposition and neuromuscular blocking effect of atracurium , 1990, Clinical pharmacology and therapeutics.
[46] R. Vaughan,et al. Volume and pH of gastric juice in obese patients. , 1975, Anesthesiology.
[47] M. Robson,et al. Becaplermin gel in the treatment of pressure ulcers: a phase II randomized, double‐blind, placebo‐controlled study , 1999, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[48] C. Ireton-Jones,et al. Actual or ideal body weight: which should be used to predict energy expenditure? , 1991, Journal of the American Dietetic Association.
[49] B. Ghorayeb. Tracheotomy in the morbidly obese patient. , 1987, Archives of otolaryngology--head & neck surgery.
[50] Mayank Patel,et al. Critical care of the obese and bariatric surgical patient. , 2003, Critical care clinics.
[51] R. Farinotti,et al. Propofol Infusion for Maintenance of Anesthesia in Morbidly Obese Patients Receiving Nitrous Oxide A Clinical and Pharmacokinetic Study , 1993, Anesthesiology.
[52] E. A. Nelson,et al. Systematic reviews of wound care management: (5) beds; (6) compression; (7) laser therapy, therapeutic ultrasound, electrotherapy and electromagnetic therapy. , 2001, Health technology assessment.
[53] M Schetz,et al. Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.
[54] E. Nutescu,et al. Dosing and Monitoring of Low‐Molecular‐Weight Heparins in Special Populations , 2001, Pharmacotherapy.
[55] A. Giles,et al. College of American Pathologists Conference XXXI on Laboratory Monitoring of Anticoagulant Therapy , 1998 .
[56] B. Bistrian,et al. Intensive insulin therapy in critically ill patients. , 2002, The New England journal of medicine.
[57] B. Boutouyrie,et al. The pharmacokinetics and pharmacodynamics of enoxaparin in obese volunteers , 2002, Clinical pharmacology and therapeutics.
[58] M. Herrera,et al. Role of Radiologic Contrast Studies in the Early Postoperative Period After Bariatric Surgery , 1999, Obesity surgery.
[59] G. Guyatt,et al. Adaptation to the Intensive Care Environment (ATICE): Development and validation of a new sedation assessment instrument , 2003, Critical care medicine.
[60] M. Armstrong. Obesity as an intrinsic factor affecting wound healing. , 1998, Journal of wound care.
[61] D. Scholten,et al. A Comparison of Two Different Prophylactic Dose Regimens of Low Molecular Weight Heparin in Bariatric Surgery , 2002, Obesity surgery.
[62] G. Cheymol. Effects of Obesity on Pharmacokinetics , 2000 .
[63] K. Mizutani,et al. Fentanyl inhibits metabolism of midazolam: competitive inhibition of CYP3A4 in vitro. , 1999, British journal of anaesthesia.
[64] J. Helterbrand,et al. Efficacy and safety of recombinant human activated protein C for severe sepsis , 2003 .
[65] Deborah H. Kim. Practice Parameters for Intravenous Analgesia and Sedation for Adult Patients in the Intensive Care Unit: An Executive Summary , 1996 .